About Formation Bio
Formation Bio is a tech-driven, AI-native pharmaceutical company focused on radically more efficient drug development. It has built a technology platform that optimizes clinical drug development — enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharma and biotech companies and develops them faster to accelerate patient access to new treatments and unlock greater value per program.
Company details
Funding
Total raised
$608M
Last stage
Growth
Investors
Founders
Kit Dobyns
Cornell undergraduate and Rhodes Scholar at Oxford. Met Benjamine Liu during the Rhodes Scholar pre-orientation at Oxford. Left Formation Bio in 2019 to found Cayaba Care, a maternity services provider.
Benjamine Liu
Rhodes Scholar DPhil from Oxford in computational biology (AI/ML for Parkinson's and Alzheimer's diagnostics). Previously a computational biologist at the Translational Neuroscience and Dementia Research Group. Also serves as Advisor to Harvard Business School's MS/MBA Biotechnology Program.
LinkedInLinhao Zhang
BS in Computer Science from University of Texas at Austin. Previously a software engineer at Salesforce and product engineer at Oscar Health. Served as CTO then COO at Formation Bio; stepped down from CTO role in August 2025.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.